Tom Frohlich co-founded and joined Chinook Therapeutics in January 2019. Previously, he served as entrepreneur-in-residence at Versant Ventures. From 2014 to 2018, Frohlich was vice-president of business development at Arbutus Biopharma, and prior to that, he spent more than 12 years working internationally at Johnson & Johnson and Merck.

GREATEST SUCCESS: Co-founding Chinook Therapeutics in order to develop new therapies for kidney disease.
NON-PROFIT CAUSE: Ovarian cancer research. My wife is an ovarian cancer survivor and national board chair of Ovarian Cancer Canada.
BUCKET LIST: I dream of going on a heli-ski trip.
Childhood dream job: I wanted to be a part-time doctor at a ski resort.